Navigation Links
NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
Date:11/9/2007

CORAL GABLES, Fla., Nov. 9 /PRNewswire/ -- NTM Info & Research (NTMir), a not-for-profit organization that supports education and research for nontuberculous mycobacterial (NTM) lung disease announces the implementation of Rapid Information Pilot Studies (RIPS(TM)), an innovative program to provide guidance about pressing issues regarding NTM host vulnerability, sources of infection, and clinical and treatment issues. Small pilot studies will be conducted so that information will be available within 12 months of grant approval, and will justify large-scale, multi-centered studies to explore the issues identified by the RIPS(TM) program.

NTMir is pleased to announce that it has awarded a RIPS(TM) grant to Dr. Joseph Falkinham, III, at Virginia Tech in Blacksburg, Virginia to study household water systems as a source of pulmonary NTM infection. This project will be initiated and completed during 2008, providing important information regarding the risk factors associated with household water and NTM lung infection. This study will be the first in a series designed to better understand both environmental and host factors of human infection with NTM.

NTMir is pleased to announce that it has awarded a RIPS(TM) grant jointly to National Institute of Allergy and Infectious Disease (NIAID) and Kaiser Permanente of Southern California (Kaiser), a private healthcare provider, to study the prevalence, prevalence trends, and co-morbidities of pulmonary NTM disease. This study represents an opportunity to evaluate the prevalence of NTM within a closed healthcare system and a unique partnership between a federal government agency (NIAID), a private healthcare system (Kaiser), and a disease-centered not-for-profit organization (NTMir).


'/>"/>
SOURCE NTM Info & Research
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):